The COMBINE project is committed to sustaining #AMRresearch efforts! .Explore results from the @AMRAccelerator projects:. @IMI_ERA4TB .@UNITE4TB.

One-Stop Resource for the Latest Developments Against AMR!. The ‘Webinar Archive’ page on our website is a comprehensive collection addressing antimicrobial resistance. 👉 Visit today:

Can’t Attend the Live Webinar on 13th February? No Problem!. 👉 Submit your registration now and receive the recording to watch at a time that works best for you:

Looking for a Snapshot of our Accelerator Projects?✨. The '𝗣𝗿𝗼𝗷𝗲𝗰𝘁 𝗣𝗼𝗿𝘁𝗳𝗼𝗹𝗶𝗼 𝗣𝗮𝗴𝗲' has it all !.The interactive table showcases detailed view of our accelerator projects aimed at combating AMR. 👉 Check out our Portfolio page now

Learn how:.1️⃣ We built AntiMicrobial-KG, a knowledge graph of antibacterial assay data, and used it to train ML models to find antimicrobial compounds. 2️⃣ Our Random Forest model hit 75.9% accuracy and predicted active compounds in EU-OpenScreen and Enamine libraries.

How Can We Combat Superbugs?. Hear from Nasreen Hassoun Kheir, lead author of a recent PrIMAVeRa perspective article and infectious diseases expert, as she shares her journey and insights in an exclusive interview. 👉 Read the full interview at:

Reserve your spot today for the upcoming webinar on leveraging Machine Learning (ML)–Tool to address the challenges of antibiotic drug discovery amidst rising AMR. Join us on February 13, 2025, 15:00 - 16:30 CET. 👉 Register now to secure your spot:

RT @AMRAccelerator: 𝗙𝗶𝗻𝗱 𝗢𝘂𝘁 𝗪𝗵𝗮𝘁’𝘀 𝗔𝗵𝗲𝗮𝗱 𝗳𝗼𝗿 𝗬𝗼𝘂 𝗪𝗶𝘁𝗵 𝗨𝘀 𝗶𝗻 𝟮𝟬𝟮𝟱! ✨. Stay tuned with us for:.💻 More & More Webinars.🔬 Projects under AMR….

Discover links to public webinars, interviews with early career researchers, and many more insights from AMR Accelerator projects in the December issue!.

RT @gardp_amr: 🚨Naming Challenge Alert 🚨. Neisseria gonorrhoeae is resistant to nearly all types of all types of antibiotics used to treat….

RT @AMRAccelerator: Stay in the loop: Sign up for our newsletter and get the latest updates, insights, and exclusi….

RT @UAC_UU: This week we learn about the access to #antibiotics in the Nordic Region 🇸🇪 🇩🇰 🇳🇴 🇫🇮, in a conference organized by the @LV_MPA….

Our consortium member grit42 announced that the grit Scientific Data Management Platform will be released for free!.Platforms like this drive #collaboration and #sustainability of #AMRresearch while promoting #OpenScience and #innovation. Read more:

The fifth COMBINE Annual meeting gathered on October 28-29 in Madrid for an update on the main achievements and an outlook plan to ensure the project’s legacy beyond its lifetime.

Accessing content from Nature Reviews Drug Discovery requires a subscription. Therefore, we are providing free access to a digital reprint of the article from our website:

The webinar is free for the public, but you need to register!. Secure your spot now:.

🚨🚨🚨.Join us and @IMI_ERA4TB for a #webinar with Dr. Radu Botgros from @EMA_News on November 6, 15:00 CET! .Learn how to engage w/ the EMA on drug and vaccine development now: #AntimicrobialResistance #AMR #DrugDevelopment #VaccineResearch #PublicHealth

RT @AMRAccelerator: #Antibiotic resistance threatens the vision to eradicate #tuberculosis by 2035. @IMI_ERA4TB emphasizes the need to main….

We are proud that our coordinator, Anders Karlén, received the Pharmacist of the Year 2024 Award from the Swedish Pharmacists Association!. "I am very honored by the award and of having the privilege to work with a very committed team", says Anders.

RT @crb_uu: JUST PUBLISHED: The AMR Accelerator: from individual organizations to efficient antibiotic development partnerships @NatRevDrug….

RT @npjAMR: Five years in, a reflection on the #AMR Accelerator programme's value, results and key challenges: ensuring the sustainability….